Shares of Eli Lilly (NYSE: LLY), a pharmaceuticals giant and maker of the Mounjaro GLP-1 weight loss drug, jumped 3.2% through 12:50 p.m. ET Wednesday after Reuters reported it's expanding its Mounjaro business in India. Additionally, Lilly got a new price target from Cantor Fitzgerald this morning.

But that news was both bad and good.

Image source: Getty Images.

Continue reading

Source Fool.com